CTSK and osteoporosis: Odanacatib 74 (MK-0822) (Scheme 72) is a selective inhibitor of CathepsinK activity, developed byMerck for the treatment of osteoporosis and bone metastasis.328 Osteoporosis is characterized by abundant boneloss, causing skeletal fragility, along with an increased risk offracture.